Histomorphometric Analysis of 38 Giant Cell Tumors of Bone after Recurrence as Compared to Changes Following Denosumab Treatment

SIMPLE SUMMARY: Giant cell tumor of bone (GCTB) is an osteolytic tumor driven by an H3F3A-mutated mononuclear stromal cell with an accumulation of osteoclastic giant cells. Anti-RANKL antibody therapy with denosumab leads to morphological changes, and sarcomas have been described in association with...

Descripción completa

Detalles Bibliográficos
Autores principales: Arndt, Sophia, Hartmann, Wolfgang, Rókusz, András, Leinauer, Benedikt, von Baer, Alexandra, Schultheiss, Markus, Pablik, Jessica, Fritzsche, Hagen, Mogler, Carolin, Antal, Imre, Baumhoer, Daniel, Mellert, Kevin, Möller, Peter, Szendrői, Miklós, Jundt, Gernot, Barth, Thomas F. E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486357/
https://www.ncbi.nlm.nih.gov/pubmed/37686526
http://dx.doi.org/10.3390/cancers15174249

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486357/
https://www.ncbi.nlm.nih.gov/pubmed/37686526
http://dx.doi.org/10.3390/cancers15174249

Ejemplares similares